Galena Biopharma

Galena Biopharma

Galena Biopharma

Galena Biopharma is a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments to advance cancer care.
Founded
2011
Raised
$24M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$24,000,000
Post-IPO debt - 2016
Team Size
1–10
Employees
The Motley Fool

These 2 Catalysts Helped Push Galena Biopharma, Inc. 31% Higher in May

The Motley Fool

Why Galena Biopharma, Inc. Was on the Fast Track to a Higher Stock Price Today

The Motley Fool

The Single Reason Why Galena Biopharma, Inc. Rallied 67% in March

Health Stock markets
The Motley Fool

Why Galena Biopharma Inc PRESENTed a Higher Stock Price

The Motley Fool

Galena Biopharma Gives Shareholders 3 More Reasons to Bury Their Heads in the Sand --

The Motley Fool

3 Things Galena Biopharma Inc. Wants You to Know --

Health Stock markets Earnings
The Motley Fool

Galena Biopharma's 3rd-Quarter Report Is Nothing Short of Bizarre --

Health Stock markets
The Motley Fool

Here's Why Galena Biopharma's Stock Tanked Today --

The Motley Fool

4 Questions to Ask Ahead of Galena Biopharma's Third-Quarter Earnings Report --

Stock markets Health Earnings